Stability of hematologic and visceral parameters. (A) Composite primary end point (relative to change from baseline) and (B) prespecified therapeutic goals based on entry criteria and goals established for patients on enzyme therapy (absolute value). Error bars denote upper and lower 95% confidence intervals.